Deep transfer learning of cancer drug responses by integrating bulk and single-cell RNA-seq data
Top Cited Papers
Open Access
- 30 October 2022
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-13
Abstract
Drug screening data from massive bulk gene expression databases can be analyzed to determine the optimal clinical application of cancer drugs. The growing amount of single-cell RNA sequencing (scRNA-seq) data also provides insights into improving therapeutic effectiveness by helping to study the heterogeneity of drug responses for cancer cell subpopulations. Developing computational approaches to predict and interpret cancer drug response in single-cell data collected from clinical samples can be very useful. We propose scDEAL, a deep transfer learning framework for cancer drug response prediction at the single-cell level by integrating large-scale bulk cell-line data. The highlight in scDEAL involves harmonizing drug-related bulk RNA-seq data with scRNA-seq data and transferring the model trained on bulk RNA-seq data to predict drug responses in scRNA-seq. Another feature of scDEAL is the integrated gradient feature interpretation to infer the signature genes of drug resistance mechanisms. We benchmark scDEAL on six scRNA-seq datasets and demonstrate its model interpretability via three case studies focusing on drug response label prediction, gene signature identification, and pseudotime analysis. We believe that scDEAL could help study cell reprogramming, drug selection, and repurposing for improving therapeutic efficacy.Keywords
Funding Information
- U.S. Department of Health & Human Services | National Institutes of Health (R35-GM126985, R01GM131399)
- National Science Foundation (NSF1945971)
- U.S. Department of Health & Human Services | National Institutes of Health
This publication has 52 references indexed in Scilit:
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cellsNucleic Acids Research, 2012
- Cisplatin Resistance: A Cellular Self-Defense Mechanism Resulting from Multiple Epigenetic and Genetic ChangesPharmacological Reviews, 2012
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012
- BUB1 and BUBR1: multifaceted kinases of the cell cycleTrends in Biochemical Sciences, 2011
- Error-prone translesion synthesis mediates acquired chemoresistanceProceedings of the National Academy of Sciences, 2010
- Oncogenes and Tumor Suppressor GenesCold Spring Harbor Perspectives in Biology, 2010
- How the Fanconi Anemia Pathway Guards the GenomeAnnual Review of Genetics, 2009
- Homologous recombination in DNA repair and DNA damage toleranceCell Research, 2008
- Mitotic checkpoint defects in human cancers and their implications to chemotherapyFrontiers in Bioscience-Landmark, 2008
- Artificial neural networks (the multilayer perceptron)—a review of applications in the atmospheric sciencesAtmospheric Environment, 1998